The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type - Implications for the role of amyloid-beta 1-42 in Alzheimer's disease

被引:83
|
作者
Castano, EM
Prelli, F
Soto, C
Beavis, R
Matsubara, E
Shoji, M
Frangione, B
机构
[1] NYU,MED CTR,DEPT NEUROL,NEW YORK,NY 10016
[2] NYU,MED CTR,DEPT PHARMACOL,NEW YORK,NY 10016
[3] GUNMA UNIV,SCH MED,DEPT NEUROL,GUNMA 371,JAPAN
关键词
D O I
10.1074/jbc.271.50.32185
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCEFWA-D), a genetic variant (E22Q) of amyloid beta (A beta) accumulates predominantly in the small vessels of leptomeninges and cerebral cortex, leading to fatal strokes in the fifth or sixth decade of life, A beta deposition in the neuropil occurs mainly in the form of preamyloid, Congo red negative deposits, while mature neuritic plaques and neurofibrillary tangles, hallmark lesions in Alzheimer's disease (AD), are characteristically absent, A recent hypothesis regarding the patho genesis of AD states that A beta extending to residues 42-43 (as opposed to shorter species) can seed amyloid formation and trigger the development of neuritic plaques followed by neuronal damage in AD. We characterized biochemically and immunohistochemically A beta from three cases of HCHWA-D to determine its length in vascular and parenchymal deposits, Mass spectrometry of formic acid-soluble amyloid, purified by size-exclusion gel chromatography, showed that A beta 1-40 and its carboxyl-terminal truncated derivatives were the predominant forms in leptomeningeal and cortical vessels, A beta 1-42 was a minor component in these amyloid extracts, Immunohistochemistry with antibodies S40 and S42, specific for A beta ending at Val-40 or Ala-42, respectively, were consistent with the biochemical data from vascular amyloid. In addition, parenchymal preamyloid lesions were specifically stained with S42 and were not labeled by S40, in agreement with the pattern reported for AD, Down's syndrome, and aged dogs, Our results suggest that in HCHWA-D the carboxyl-terminal A beta heterogeneity is due to limited proteolysis in vivo, Moreover, they suggest that A beta species ending at Ala-42 may not be critical for the seeding of amyloid formation and the development of AD-like neuritic changes.
引用
收藏
页码:32185 / 32191
页数:7
相关论文
共 50 条
  • [41] Exploring the role of the histidine residues in the Alzheimer's disease Amyloid-beta peptide
    Smith, DG
    Ciccotosto, GG
    Curtain, CC
    Masters, CL
    Cappai, R
    Barnham, KJ
    FEBS JOURNAL, 2005, 272 : 537 - 537
  • [42] Role of Cdk5 in Amyloid-beta Pathology of Alzheimer's Disease
    Lu, Tao-Tao
    Wan, Chengqun
    Yang, Wenming
    Cai, Zhiyou
    CURRENT ALZHEIMER RESEARCH, 2019, 16 (13) : 1206 - 1215
  • [43] The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease
    Catalano, Susan M.
    Dodson, Elizabeth C.
    Henze, Darrell A.
    Joyce, Joseph G.
    Krafft, Grant A.
    Kinney, Gene G.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (06) : 597 - 608
  • [44] Amyloid-beta peptide in atherogenesis: A novel role beyond Alzheimer's disease
    Li, L
    Wan, HQ
    Cao, DF
    Fukuchi, KI
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E18 - E18
  • [45] Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease
    Tabaton, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S205 - S205
  • [46] Identifying The Normal Function of Amyloid-Beta and Its Role in Alzheimer's Disease
    Hunsucker, Rachel
    Atamna, Hani
    Vo, Triet
    NEUROLOGY, 2023, 100 (17)
  • [47] Purification of recombinantly expressed and cytotoxic human amyloid-beta peptide 1-42
    Wiesehan, Katja
    Funke, Susanne Aileen
    Fries, Miriam
    Willbold, Dieter
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 856 (1-2): : 229 - 233
  • [48] Clinical use and analytical problems in amyloid-beta(1-42) and tau protein in cefalorachidic fluid as markers of Alzheimer's disease
    Kang, Ju-Hee
    Korecka, Magdalena
    Toledo, Jon B.
    Trojanowski, John Q.
    Shaw, Leslie M.
    BIOCHIMICA CLINICA, 2014, 38 (03) : 255 - 267
  • [49] Oligomeric Forms of Human Amyloid-Beta(1-42) Inhibit Antigen Presentation
    Gericke, Christoph
    Mallone, Anna
    Engelhardt, Britta
    Nitsch, Roger M.
    Ferretti, Maria Teresa
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [50] Complement interactions with amyloid-beta 1-42: a nidus for inflammation in AD brains
    Watson, MD
    Roher, AE
    Kim, KS
    Spiegel, K
    Emmerling, MR
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 1997, 4 (03): : 147 - 156